InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+21.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Poole Sandra, Director. Director active across 1 company, notably Travere Therapeutics, Inc.. In total, 6 reports have been logged. Activity tracked since 14 May 2021. The latest transaction was disclosed on 15 May 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
6,500 shares0Common StockSEC:0001415889-25-013502:0
6,500 shares0Common StockSEC:0001415889-24-012850:0
4,500 shares0Common StockSEC:0001209191-23-030965:0
3,000 shares0Common StockSEC:0001209191-22-028701:0
3,000 shares0Common StockSEC:0001209191-21-033846
3,000 shares0Common StockSEC:0001209191-21-033846:0
6 of 6 declarations
About Poole Sandra
Sandra Poole is a Director at Travere Therapeutics, Inc. She plays a key role in overseeing the company's activities and making strategic decisions. Her experience is valuable for guiding Travere towards sustainable growth and optimal performance.
